Android Apple

Karyopharm Therapeutics Inc. (KPTI) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.62

south_east -$0.02 (-2.97%)
Day's range
$0.6
Day's range
$0.66

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
06/10/2024 RBC Capital Brian Abrahams $3.00 $0.95   215.42%
No analyst forecast available for this stock.

Karyopharm Therapeutics Inc. FAQ's

What analysts cover Karyopharm Therapeutics Inc.?

Karyopharm Therapeutics Inc. has been rated by research analysts at RBC Capital, Leerink Partners, Robert W. Baird in the past 90 days.

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.